CircLRBA Promotes Epithelial-Mesenchymal Transition, Immune Evasion, Chemoimmunotherapy Resistance and Metastasis Through Stabilizing Twist1

CircLRBA通过稳定Twist1促进上皮-间质转化、免疫逃逸、化疗免疫治疗耐药性和转移。

阅读:3

Abstract

Breast cancer (BC) is a malignant tumor with the highest incidence in women. Metastasis is the leading cause of BC-related death. Circular RNAs (circRNAs) play important roles in cancer progression and metastasis, therefore exploring its specific mechanism in BC metastasis has high value. However, the biological roles and potential mechanism of circRNAs in BC remain unclear. Here, a highly expressed circRNA circLRBA in BC tissues is identified using high-throughput sequencing, which is associated with pathological stage and poor overall survival. Functional assays show that circLRBA facilitates BC cell proliferation, invasion, migration, docetaxel (DTX) resistance, and inhibits the infiltration of CD8+ T cell in vitro and in vivo. Whereas circLRBA knockdown reveals opposite roles. Mechanistically, transcription factor Zeb1 promotes the generation of circLRBA. Importantly, circLRBA could competitively combine with E3 ubiquitin ligase SPOP to suppress the Twist1 ubiquitination degradation and enhances PD-L1 transcriptional activity, thus promoting EMT, immune evasion, chemoresistance and BC progression. This study highlights the oncogenic role of circLRBA in BC progression through its binding with SPOP to increases Twist1 stability, suggesting that circLRBA might serve as a promising biomarker and potential therapeutic target for BC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。